David Liu, Ph.D.

Senior Analyst

Dr. Liu joins the firm as Senior Analyst covering Biotech. Prior to joining Iguana, David was a Research Associate at RBC Capital Markets covering small and mid cap biotech. With over 8 years of scientific research experience, David brings to the firm an extensive scientific background, with a particular focus on oncology. David conducted his doctoral thesis and post-doctoral research at Memorial Sloan-Kettering Cancer Center, where he studied mechanisms of resistance to anti-cancer therapeutics. David received his B.S. with Honors in Biological Sciences from Stanford University and a Ph.D. in Molecular Biology from Cornell University.